Cargando…
Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro
The human TAR RNA-binding protein (hTRBP) and protein activator of protein kinase R (hPACT) are important players in RNA interference (RNAi). Together with hArgonaute2 (hAgo2) and hDicer they have been reported to form the RISC-loading complex (RLC). Among other functions, hTRBP was suggested to ass...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718636/ https://www.ncbi.nlm.nih.gov/pubmed/26784517 http://dx.doi.org/10.1371/journal.pone.0146814 |
_version_ | 1782410830563770368 |
---|---|
author | Willkomm, Sarah Deerberg, Andrea Heidemann, Johannes Flügge, Friedemann Meine, Janica Hu, Rui Kretschmer-Kazemi Far, Rosel Restle, Tobias |
author_facet | Willkomm, Sarah Deerberg, Andrea Heidemann, Johannes Flügge, Friedemann Meine, Janica Hu, Rui Kretschmer-Kazemi Far, Rosel Restle, Tobias |
author_sort | Willkomm, Sarah |
collection | PubMed |
description | The human TAR RNA-binding protein (hTRBP) and protein activator of protein kinase R (hPACT) are important players in RNA interference (RNAi). Together with hArgonaute2 (hAgo2) and hDicer they have been reported to form the RISC-loading complex (RLC). Among other functions, hTRBP was suggested to assist the loading of hAgo2 with small interfering RNAs (siRNAs) within the RLC. Although several studies have been conducted to evaluate the specific functions of hTRBP and hPACT in RNAi, exact mechanisms and modes of action are still unknown. Here, we present a biochemical study further evaluating the role of hTRBP and hPACT in hAgo2-loading. We found that both proteins enhance hAgo2-mediated RNA cleavage significantly; even a hAgo2 mutant impaired in siRNA binding shows full cleavage activity in the presence of hTRBP or hPACT. Pre-steady state binding studies reveal that the assembly of wildtype-hAgo2 (wt-hAgo2) and siRNAs remains largely unaffected, whereas the binding of mutant hAgo2-PAZ9 to siRNA is restored by adding either hTRBP or hPACT. We conclude that both proteins assist in positioning the siRNA within hAgo2 to ensure optimal binding and cleavage. Overall, our data indicate that hTRBP and hPACT are part of a regulative system of RNAi that is important for efficient target RNA cleavage. |
format | Online Article Text |
id | pubmed-4718636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47186362016-01-30 Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro Willkomm, Sarah Deerberg, Andrea Heidemann, Johannes Flügge, Friedemann Meine, Janica Hu, Rui Kretschmer-Kazemi Far, Rosel Restle, Tobias PLoS One Research Article The human TAR RNA-binding protein (hTRBP) and protein activator of protein kinase R (hPACT) are important players in RNA interference (RNAi). Together with hArgonaute2 (hAgo2) and hDicer they have been reported to form the RISC-loading complex (RLC). Among other functions, hTRBP was suggested to assist the loading of hAgo2 with small interfering RNAs (siRNAs) within the RLC. Although several studies have been conducted to evaluate the specific functions of hTRBP and hPACT in RNAi, exact mechanisms and modes of action are still unknown. Here, we present a biochemical study further evaluating the role of hTRBP and hPACT in hAgo2-loading. We found that both proteins enhance hAgo2-mediated RNA cleavage significantly; even a hAgo2 mutant impaired in siRNA binding shows full cleavage activity in the presence of hTRBP or hPACT. Pre-steady state binding studies reveal that the assembly of wildtype-hAgo2 (wt-hAgo2) and siRNAs remains largely unaffected, whereas the binding of mutant hAgo2-PAZ9 to siRNA is restored by adding either hTRBP or hPACT. We conclude that both proteins assist in positioning the siRNA within hAgo2 to ensure optimal binding and cleavage. Overall, our data indicate that hTRBP and hPACT are part of a regulative system of RNAi that is important for efficient target RNA cleavage. Public Library of Science 2016-01-19 /pmc/articles/PMC4718636/ /pubmed/26784517 http://dx.doi.org/10.1371/journal.pone.0146814 Text en © 2016 Willkomm et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Willkomm, Sarah Deerberg, Andrea Heidemann, Johannes Flügge, Friedemann Meine, Janica Hu, Rui Kretschmer-Kazemi Far, Rosel Restle, Tobias Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro |
title | Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro |
title_full | Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro |
title_fullStr | Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro |
title_full_unstemmed | Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro |
title_short | Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro |
title_sort | recombinant htrbp and hpact modulate hago2-catalyzed sirna-mediated target rna cleavage in vitro |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718636/ https://www.ncbi.nlm.nih.gov/pubmed/26784517 http://dx.doi.org/10.1371/journal.pone.0146814 |
work_keys_str_mv | AT willkommsarah recombinanthtrbpandhpactmodulatehago2catalyzedsirnamediatedtargetrnacleavageinvitro AT deerbergandrea recombinanthtrbpandhpactmodulatehago2catalyzedsirnamediatedtargetrnacleavageinvitro AT heidemannjohannes recombinanthtrbpandhpactmodulatehago2catalyzedsirnamediatedtargetrnacleavageinvitro AT fluggefriedemann recombinanthtrbpandhpactmodulatehago2catalyzedsirnamediatedtargetrnacleavageinvitro AT meinejanica recombinanthtrbpandhpactmodulatehago2catalyzedsirnamediatedtargetrnacleavageinvitro AT hurui recombinanthtrbpandhpactmodulatehago2catalyzedsirnamediatedtargetrnacleavageinvitro AT kretschmerkazemifarrosel recombinanthtrbpandhpactmodulatehago2catalyzedsirnamediatedtargetrnacleavageinvitro AT restletobias recombinanthtrbpandhpactmodulatehago2catalyzedsirnamediatedtargetrnacleavageinvitro |